nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

30.08.2016 | comment – reprint

Developments in neuro-oncology

verfasst von: Silvia Hofer, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Summary

A short statement on the most recent developments in the neuro-oncology field, including the new WHO Classification of Tumors of the Central Nervous System (2016) and current treatment strategies.

Vorheriger Artikel Pulmonary mass: never judge a book by its cover

Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20. doi:10.1007/s00401-016-1545-1.CrossRefPubMed

Seystahl K, Gramatzki D, Roth P, Weller M. Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives. Expert Opin Pharmacother. 2016;17(9):1259–70.CrossRefPubMed

Li X, Wu C, Chen N, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22) doi:10.18632/oncotarget.7961.CrossRefPubMedPubMedCentral

Buckner JC, Shaw EG, Pugh SL, et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med. 2016;374(14):1344–55. doi:10.1056/NEJMoa1500925.CrossRefPubMedPubMedCentral

Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 2013;31:337–43CrossRefPubMedPubMedCentral

van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31:344–50.CrossRefPubMed

Faulkner C, Ellis HP, Shaw A, et al. BRAF fusion analysis in pilocytic astrocytomas: KIAA1549-BRAF 15-9 fusions are more frequent in the midline than within the cerebellum. J Neuropathol Exp Neurol. 2015;74(9):867–72.CrossRefPubMedPubMedCentral

Titel: Developments in neuro-oncology
verfasst von: Silvia Hofer, MD
Publikationsdatum: 30.08.2016
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-016-0278-0

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Update of clinical highlights presented at the 2017 American Society of Hematology Meeting

Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting

APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania

ASH 2017: highlights in chronic myeloid leukemia

Educational no. 1: Bone marrow diagnostics in hemato-oncological diseases

Update and clinical highlights presented at the 2017 American Society of Hematology Meeting